Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC
NCT04284215
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Efficacy and Safety
Interventions
DRUG:
Albumin paclitaxel combined with cisplatin
Sponsor
Guizhou Medical University